This is a double-blind, randomized, placebo-controlled crossover outpatient study in patients
with peripheral neuropathic pain with allodynia or hyperalgesia to cold, heat, brush and/ or
pinprick stimulation. Patients will in random order receive ACD440 Gel or placebo treatment
twice daily for 7 days, topically applied to the painful area. This is followed by a 2-week
washout period, then receive the alternate treatment.
If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.